Evidence map›Paper›PMID 42418033›Full record

ArticleJournal of molecular modeling2026

Mechanisms of the binding of camptothecin derivatives with topoisomerase I: Molecular docking, molecular dynamics simulations, and binding free energy calculations.

Jingli Liu, Jingyu Qu, Yingying Xue, Yajun Shi, Mingsong Shi

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of molecular modeling, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jingli LiuCollege of Pharmacy, Shaanxi University of Chinese Medicine, 712046, Xianyang, Shaanxi, People's Republic of China.
Jingyu QuCollege of Pharmacy, Shaanxi University of Chinese Medicine, 712046, Xianyang, Shaanxi, People's Republic of China.
Yingying XueCollege of Pharmacy, Shaanxi University of Chinese Medicine, 712046, Xianyang, Shaanxi, People's Republic of China.
Yajun ShiCollege of Pharmacy, Shaanxi University of Chinese Medicine, 712046, Xianyang, Shaanxi, People's Republic of China. 2051004@sntcm.edu.cn.
Mingsong ShiNational Health Commission Key Laboratory of Nuclear Technology Medical Transformation, School of Medicine, Mianyang Central Hospital, University of Electronic Science and Technology of China, Mianyang, Sichuan, 621099, People's Republic of China. shims90@sc-mch.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextTopoisomerase 1 (TOP1) is a key anticancer target, and camptothecin (CPT) and its derivatives are typical TOP1 inhibitors. Among them, the 7-aminourea and 7-aminothiourea derivatives of CPT (XSJ07 and XSJ05, respectively) exhibit potent inhibitory activity, yet their binding mechanisms remain unclear. In this study, we investigated the interactions of XSJ05 and XSJ07 with TOP1 to clarify their molecular recognition behavior. Both compounds intercalated into the cleaved-DNA-binding site to form stable TOP1-DNA-ligand ternary complexes. The calculated binding free energies of the XSJ05/TOP1 and XSJ07/TOP1 systems were -58.34 and -51.60 kcal/mol, respectively. These findings provide mechanistic insights into the binding of CPT derivatives to TOP1 and may guide the rational design of novel CPT-based inhibitors.

methodsMolecular docking, molecular dynamics (MD) simulations, and binding free energy calculations were employed to characterize the interactions of XSJ05 and XSJ07 with TOP1. Ligand structures were optimized at the B3LYP/6-311++G(d,p) level, and partial atomic charges were derived using the RESP protocol based on HF/6-31G calculations in Gaussian 16. Docking was performed using AutoDock 4.2 with grid parameters defined from the TPT/TOP1 crystal structure. MD simulations of the ligand-TOP1-DNA ternary complexes were conducted using AMBER24 with the ff19SB force field for TOP1 and DNA, GAFF2 for the ligands, and explicit TIP3P water. Each system was equilibrated and simulated for 500 ns in triplicate. Binding free energies and per-residue energy decompositions were calculated using the MM/GBSA method implemented in AMBER Tools, with analysis performed using the CPPTRAJ module.

Indexed as

CamptothecinDNA Topoisomerases, Type IMolecular Docking SimulationMolecular Dynamics SimulationTopoisomerase I InhibitorsBinding SitesDNAHumansLigandsProtein BindingThermodynamicsCamptothecinDNADNA Topoisomerases, Type ILigandsTOP1 protein, humanTopoisomerase I InhibitorsCamptothecin derivativesMolecular dockingMolecular dynamics simulationsTopoisomerase 1 (TOP1)

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.